Lung Cancer, Nonsmall Cell, Stage I Completed Phase 2 Trials for Nivolumab (DB09035)

Also known as: NSCLC, Stage I / Stage I NSCLC / Stage I Non-Small Cell Lung Cancer / Non-small Cell Lung Cancer Stage I / Lung cancer non-small cell stage I

IndicationStatusPhase
DBCOND0081601 (Lung Cancer, Nonsmall Cell, Stage I)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02823990TG4010 and Nivolumab in Patients With Lung CancerTreatment